Cargando…
Comparative effectiveness of furosemide vs torasemide in symptomatic therapy in heart failure patients: A randomized controlled study protocol
BACKGROUND: We performed this randomized controlled study protocol to investigate the efficacy and adverse effects of furosemide vs torasemide in patients with heart failure (HF). METHOD: The present study was authorized by the local research ethics committee of Shanxi Cardiovascular Hospital (no. 4...
Autores principales: | Li, Yifan, Li, Li, Guo, Zhipeng, Zhang, Shunye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899842/ https://www.ncbi.nlm.nih.gov/pubmed/33607802 http://dx.doi.org/10.1097/MD.0000000000024661 |
Ejemplares similares
-
Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial
por: Balsam, Paweł, et al.
Publicado: (2020) -
Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial
por: Gao, Yibing, et al.
Publicado: (2021) -
Comparison of continuous infusion and intermittent boluses of furosemide in acute heart failure: A protocol for systematic review and meta-analysis
por: Wang, Tao, et al.
Publicado: (2021) -
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure
por: Ballester, Maria Rosa, et al.
Publicado: (2015) -
Improvement of Shen’ge formula on heart function in diastolic heart failure: A protocol for randomized, double-blind, placebo-controlled clinical study
por: Qiu, Boyong, et al.
Publicado: (2021)